Active Control Lotion News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Active Control Lotion. Real-time updates on events, politics, business and more.

HOTH THERAPEUTICS REPORTS POSITIVE BIOLEXA PHASE 1B CLINICAL TRIAL RESULTS IN MILD TO MODERATE ATOPIC DERMATITIS

October 31, 2022

MEETS PRIMARY AND SECONDARY ENDPOINTS SAFETY AND EFFICACYBIOLEXA led to significant improvement in disease severity as measured by SCORAD and EASI...

Jonathan Zippin Robb Knie Dermatology Gw School Of Medicine Research For The Department Of Dermatology Weill Medical College Of Cornell Hoth Therapeutics Inc

Source: businessinsider.com

Hoth Therapeutics Announces Preliminary Efficacy Findings From Phase 1b Clinical Trial with Mild to Moderate Atopic Dermatitis Patient Cohort

May 3, 2022

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the preliminary findings from Hoths...

Exchange Commission Lr Advisors Hoth Therapeutics Inc Prnewswire Hoth Therapeutics Inc Biolexa Lotion Eczema Area

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Active Control Lotion News Today

HOTH THERAPEUTICS REPORTS POSITIVE BIOLEXA PHASE 1B CLINICAL TRIAL RESULTS IN MILD TO MODERATE ATOPIC DERMATITIS

Hoth Therapeutics Announces Preliminary Efficacy Findings From Phase 1b Clinical Trial with Mild to Moderate Atopic Dermatitis Patient Cohort

Explore More Categories